Navigation Links
Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer
Date:7/23/2014

SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the transcarotid treatment of intra- and extra-cranial cerebrovascular disease, announced today the appointment of Michael P. Wallace to the position of Chief Technology Officer.  In this new role, Michael will lead the company's Research and Development efforts across its family of transcarotid access and treatment devices.

Prior to joining Silk Road Medical, Michael was the Vice President of Research and Development at Boston Scientific's Electrophysiology Division and previously held senior technical leadership roles at Baxano Surgical, Inc., BARRx Medical, and Boston Scientific Neurovascular / Target Therapeutics. He has over 20 years of experience in the medical device field and holds over 120 issued or pending US patents.

"The addition of Mike Wallace completes the all-star executive line up at Silk Road.  Our executives are deeply experienced in the fields of carotid and neurovascular diseases and are considered the best in the industry across marketing, clinical, operations, and R&D. Our impressive executive team and the recently announced completion of enrollment in our pivotal ROADSTER Trial positions Silk Road Medical for the promising future of transcarotid interventions," said Erica Rogers, President and Chief Executive Officer.

"I am thrilled to join Silk Road to lead the R&D team through the commercial development of its pioneering and unique ENROUTE™ Transcarotid Neuroprotection and Stent Systems for treating blockages in the artery of the neck.  Despite decades of development, traditional transfemoral carotid stenting (CAS) has been associated with an excess risk of stroke due to aortic arch catheterization and less than ideal embolic protection devices.  With Silk Road's surgically-inspired approach, we believe we can reduce the risk of stroke on par with the gold standard of carotid endarterectomy (CEA) while preserving the benefits of a less invasive stenting procedure," said Mike. "Looking forward, I am also equally excited about the opportunity to help patients with neurovascular diseases by developing a suite of products that highlights the surgeon control and procedure time advantages we believe are possible with our transcarotid access point."

About the ENROUTE Transcarotid Neuroprotection and Stent Systems

The Silk Road procedure includes a combination direct carotid access sheath and dynamic flow reversal circuit, and a carotid stent. After a tiny incision is made at the neckline, the physician inserts a small tube, called a sheath, into the carotid artery.  The sheath is connected to a device that temporarily re-directs blood flow away from the brain.  Reversing the blood flow allows a physician to place a stent inside the blockage without risk of plaque breaking off and traveling up toward the brain.  After the stent is placed successfully, flow reversal is turned off and blood flow resumes in its normal direction.  Typically, the Silk Road procedure is performed under local anesthesia and can significantly minimize recovery time and scarring for the patient.  

About Silk Road Medical, Inc.

Silk Road Medical, Inc. is a private company located in Sunnyvale, CA, that develops and manufactures minimally-invasive medical devices intended to improve the treatment of intra- and extra-cranial cerebrovascular disease through proprietary transcarotid access and treatment platforms.  Detailed information about Silk Road Medical can be found at www.silkroadmed.com.

Both the ENROUTE Transcarotid NPS and Stent System have been granted CE Mark. The ENROUTE NPS is limited by United States law to investigational use. The ENROUTE Transcarotid Stent System is not currently available in the United States.


'/>"/>
SOURCE Silk Road Medical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report
2. Edwards CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation
3. Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices
4. American Osteopathic Association Calls for Eliminating Unsolicited Requests to Purchase Medical Equipment
5. EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner
6. MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center
7. Dr. Ryan Diederich appointed to Illinois State Medical Society Council
8. Apex Medicals Respiratory Therapy Product Receives Affirmation from USITC
9. ViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting
10. DICOM Grid Secures $6 Million to Meet Growing Demand for Digital Medical Imaging in the Cloud
11. Sutter Medical Center, Sacramento Pioneers Most-Advanced Surgical Robot in California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):